Prediction of preterm birth based on machine learning using bacterial risk score in cervicovaginal fluid.


Journal

American journal of reproductive immunology (New York, N.Y. : 1989)
ISSN: 1600-0897
Titre abrégé: Am J Reprod Immunol
Pays: Denmark
ID NLM: 8912860

Informations de publication

Date de publication:
09 2021
Historique:
revised: 04 04 2021
received: 04 01 2021
accepted: 22 04 2021
pubmed: 28 4 2021
medline: 27 1 2022
entrez: 27 4 2021
Statut: ppublish

Résumé

Preterm birth (PTB) is a major cause of increased morbidity and mortality in newborns. The main cause of spontaneous PTB (sPTB) is the activation of an inflammatory response as a result of ascending genital tract infection. Despite various studies on the effects of the vaginal microbiome on PTB, a practical method for its clinical application has yet to be developed. In this case-control study, 94 Korean pregnant women with PTB (n = 38) and term birth (TB; n = 56) were enrolled. Their cervicovaginal fluid (CVF) was sampled, and a total of 10 bacteria were analyzed using multiplex quantitative real-time PCR (qPCR). The PTB and TB groups were compared, and a PTB prediction model was created using bacterial risk scores using machine learning techniques (decision tree and support vector machine). The predictive performance of the model was validated using random subsampling. Bacterial risk scoring model showed significant differences (P < 0.001). The PTB risk was low when the Lactobacillus iners ratio was 0.812 or more. In groups with a ratio under 0.812, moderate and high risk was classified as a U. parvum ratio of 4.6 × 10 Using machine learning, the bacterial risk score in CVF can be used to predict PTB.

Identifiants

pubmed: 33905152
doi: 10.1111/aji.13435
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13435

Informations de copyright

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75-84.
Ananth CV, Friedman AM, Goldenberg RL, Wright JD, Vintzileos AM. Association between temporal changes in neonatal mortality and spontaneous and clinician-initiated deliveries in the United States, 2006-2013. JAMA Pediatr. 2018;172(10):949-957.
Newnham JP, Kemp MW, White SW, Arrese CA, Hart RJ, Keelan JA. Applying precision public health to prevent preterm birth. Front Public Health. 2017;5:66.
Chan RL. Biochemical markers of spontaneous preterm birth in asymptomatic women. Biomed Res Int. 2014;2014:164081.
Jefferson KK. The bacterial etiology of preterm birth. Adv Appl Microbiol. 2012;80:1-22.
Heng YJ, Liong S, Permezel M, Rice GE, Di Quinzio MK, Georgiou HM. Human cervicovaginal fluid biomarkers to predict term and preterm labor. Front Physiol. 2015;6:151.
Park S, You YA, Yun H, et al. Cervicovaginal fluid cytokines as predictive markers of preterm birth in symptomatic women. Obstet Gynecol Sci. 2020;63(4):455-463.
Ansari A, Lee H, You YA, et al. Identification of Potential Biomarkers in the Cervicovaginal Fluid by Metabolic Profiling for Preterm Birth. Metabolites. 2020;10(9).
Dekker GA, Lee SY, North RA, McCowan LM, Simpson NA, Roberts CT. Risk factors for preterm birth in an international prospective cohort of nulliparous women. PLoS One. 2012;7(7):e39154.
Crane JM, Hutchens D. Transvaginal sonographic measurement of cervical length to predict preterm birth in asymptomatic women at increased risk: a systematic review. Ultrasound Obstet Gynecol. 2008;31(5):579-587.
Liong S, Di Quinzio MK, Fleming G, Permezel M, Rice GE, Georgiou HM. New biomarkers for the prediction of spontaneous preterm labour in symptomatic pregnant women: a comparison with fetal fibronectin. BJOG. 2015;122(3):370-379.
Fox C, Eichelberger K. Maternal microbiome and pregnancy outcomes. Fertil Steril. 2015;104(6):1358-1363.
Vinturache AE, Gyamfi-Bannerman C, Hwang J, Mysorekar IU, Jacobsson B. Maternal microbiome - A pathway to preterm birth. Semin Fetal Neonatal Med. 2016;21(2):94-99.
Fettweis JM, Serrano MG, Brooks JP, et al. The vaginal microbiome and preterm birth. Nat Med. 2019;25(6):1012-1021.
Dominguez-Bello MG. Gestational shaping of the maternal vaginal microbiome. Nat Med. 2019;25(6):882-883.
You YA, Kwon EJ, Choi SJ, et al. Vaginal microbiome profiles of pregnant women in Korea using a 16S metagenomics approach. Am J Reprod Immunol. 2019;82(1):e13124.
Stellrecht KA, Woron AM, Mishrik NG, Venezia RA. Comparison of multiplex PCR assay with culture for detection of genital mycoplasmas. J Clin Microbiol. 2004;42(4):1528-1533.
Abramovici A, Lobashevsky E, Cliver SP, Edwards RK, Hauth JC, Biggio JR. Quantitative Polymerase Chain Reaction to Assess Response to Treatment of Bacterial Vaginosis and Risk of Preterm Birth. Am J Perinatol. 2015;32(12):1119-1125.
Aaltone R, Jalava J, Laurikainen E, Kärkkäinen U, Alanen A. Cervical ureaplasma urealyticum colonization: comparison of PCR and culture for its detection and association with preterm birth. Scand J Infect Dis. 2002;34(1):35-40.
Payne MS, Newnham JP, Doherty DA, et al. A specific bacterial DNA signature in the vagina of Australian women in midpregnancy predicts high risk of spontaneous preterm birth (the Predict1000 study). Am J Obstet Gynecol. 2021;224(2):206.e1-206.e23. http://dx.doi.org/10.1016/j.ajog.2020.08.034
Manning R, James CP, Smith MC, et al. Predictive value of cervical cytokine, antimicrobial and microflora levels for pre-term birth in high-risk women. Sci Rep. 2019;9(1):11246.
Huang S, Yang J, Fong S, Zhao Q. Artificial intelligence in cancer diagnosis and prognosis: Opportunities and challenges. Cancer Lett. 2020;471:61-71.
Martin ET, Kaye KS, Knott C, et al. Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2016;37(1):88-99.
Jamthikar AD, Gupta D, Saba L, et al. Artificial intelligence framework for predictive cardiovascular and stroke risk assessment models: A narrative review of integrated approaches using carotid ultrasound. Comput Biol Med. 2020;126:104043.
Abhari S, Niakan Kalhori SR, Ebrahimi M, Hasannejadasl H, Garavand A. Artificial intelligence applications in type 2 diabetes mellitus care: focus on machine learning methods. Healthc Inform Res. 2019;25(4):248-261.
Aung MT, Yu Y, Ferguson KK, et al. Prediction and associations of preterm birth and its subtypes with eicosanoid enzymatic pathways and inflammatory markers. Sci Rep. 2019;9(1):17049.
Lee KS, Ahn KH. Application of artificial intelligence in early diagnosis of spontaneous preterm labor and birth. Diagnostics (Basel). 2020;10(9).
Fergus P, Cheung P, Hussain A, Al-Jumeily D, Dobbins C, Iram S. Prediction of preterm deliveries from EHG signals using machine learning. PLoS ONE. 2013;8(10):e77154.
Lee KA, Chang MH, Park MH, et al. A model for prediction of spontaneous preterm birth in asymptomatic women. J Womens Health (Larchmt). 2011;20(12):1825-1831.
Courtney KL, Stewart S, Popescu M, Goodwin LK. Predictors of preterm birth in birth certificate data. Stud Health Technol Inform. 2008;136:555-560.
Beck D, Foster JA. Machine learning classifiers provide insight into the relationship between microbial communities and bacterial vaginosis. BioData Min. 2015;8:23.
Leitich H, Egarter C, Kaider A, Hohlagschwandtner M, Berghammer P, Husslein P. Cervicovaginal fetal fibronectin as a marker for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 1999;180(5):1169-1176.
Conde-Agudelo A, Papageorghiou AT, Kennedy SH, Villar J. Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis. BJOG. 2011;118(9):1042-1054.
Tabatabaei N, Eren AM, Barreiro LB, et al. Vaginal microbiome in early pregnancy and subsequent risk of spontaneous preterm birth: a case-control study. BJOG. 2019;126(3):349-358.
Elovitz MA, Gajer P, Riis V, et al. Cervicovaginal microbiota and local immune response modulate the risk of spontaneous preterm delivery. Nat Commun. 2019;10(1):1305.
Witkin SS, Moron AF, Ridenhour BJ, et al. Vaginal biomarkers that predict cervical length and dominant bacteria in the vaginal microbiomes of pregnant women. MBio. 2019;10(5).
Santiago GL, Tency I, Verstraelen H, et al. Longitudinal qPCR study of the dynamics of L. crispatus, L. iners, A. vaginae, (Sialidase Positive) G. vaginalis, and P. bivia in the vagina. PLoS ONE. 2012;7(9):e45281.
Kim JH, Yoo SM, Sohn YH, et al. Predominant Lactobacillus species types of vaginal microbiota in pregnant Korean women: quantification of the five Lactobacillus species and two anaerobes. J Matern Fetal Neonatal Med. 2017;30(19):2329-2333.
Petricevic L, Domig KJ, Nierscher FJ, et al. Characterisation of the vaginal Lactobacillus microbiota associated with preterm delivery. Sci Rep. 2014;4:5136.
Oliver A, LaMere B, Weihe C, et al. Cervicovaginal microbiome composition is associated with metabolic profiles in healthy pregnancy. MBio. 2020;11(4):e01851-20.
Chu DM, Seferovic M, Pace RM, Aagaard KM. The microbiome in preterm birth. Best Pract Res Clin Obstet Gynaecol. 2018;52:103-113.
Romero R, Hassan SS, Gajer P, et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome. 2014;2(1):4.
Nasioudis D, Forney LJ, Schneider GM, et al. The composition of the vaginal microbiome in first trimester pregnant women influences the level of autophagy and stress in vaginal epithelial cells. J Reprod Immunol. 2017;123:35-39.
Ghartey JP, Smith BC, Chen Z, et al. Lactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against Escherichia coli. PLoS ONE. 2014;9(5):e96659.
Machado A, Jefferson KK, Cerca N. Interactions between Lactobacillus crispatus and bacterial vaginosis (BV)-associated bacterial species in initial attachment and biofilm formation. Int J Mol Sci. 2013;14(6):12004-12012.
Freitas AC, Bocking A, Hill JE, Money DM. Increased richness and diversity of the vaginal microbiota and spontaneous preterm birth. Microbiome. 2018;6(1):117.
Leizer J, Nasioudis D, Forney LJ, et al. Properties of epithelial cells and vaginal secretions in pregnant women when Lactobacillus crispatus or Lactobacillus iners dominate the vaginal microbiome. Reprod Sci. 2018;25(6):854-860.
Blostein F, Gelaye B, Sanchez SE, Williams MA, Foxman B. Vaginal microbiome diversity and preterm birth: results of a nested case-control study in Peru. Ann Epidemiol. 2020;41:28-34.
Petrova MI, Reid G, Vaneechoutte M, Lebeer S. Lactobacillus iners: friend or foe? Trends Microbiol. 2017;25(3):182-191.
Sprong KE, Mabenge M, Wright CA, Govender S. Ureaplasma species and preterm birth: current perspectives. Crit Rev Microbiol. 2020;46(2):169-181.
Motomura K, Romero R, Xu Y, et al. Intra-amniotic infection with ureaplasma parvum causes preterm birth and neonatal mortality that are prevented by treatment with clarithromycin. MBio. 2020;11(3).
Salim M, Wåhlin E, Dembrower K, et al. External evaluation of 3 commercial artificial intelligence algorithms for independent assessment of screening mammograms. JAMA Oncol. 2020;6(10):1581-1588.
Montazeri M, Montazeri M, Montazeri M, Beigzadeh A. Machine learning models in breast cancer survival prediction. Technol Health Care. 2016;24(1):31-42.
Lynch CM, Abdollahi B, Fuqua JD, et al. Prediction of lung cancer patient survival via supervised machine learning classification techniques. Int J Med Inform. 2017;108:1-8.
Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2015;13:8-17.
Karimi-Alavijeh F, Jalili S, Sadeghi M. Predicting metabolic syndrome using decision tree and support vector machine methods. ARYA Atheroscler. 2016;12(3):146-152.
Asadi N, Faraji A, Keshavarzi A, Akbarzadeh-Jahromi M, Yoosefi S. Predictive value of procalcitonin, C-reactive protein, and white blood cells for chorioamnionitis among women with preterm premature rupture of membranes. Int J Gynaecol Obstet. 2019;147(1):83-88.
Romero R, Yoon BH, Mazor M, et al. The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 1993;169(4):805-816.
Hill JL, Campbell MK, Zou GY, et al. Prediction of preterm birth in symptomatic women using decision tree modeling for biomarkers. Am J Obstet Gynecol. 2008;198(4):468.e461-467.

Auteurs

Sunwha Park (S)

Department of Obstetrics and Gynecology, College of Medicine, Ewha Medical Research Institute, Ewha Womans University, Seoul, Korea.

Daejoong Oh (D)

D&P Biotech, Inc, Seoul, Korea.

Hanna Heo (H)

Department of Obstetrics and Gynecology, College of Medicine, Ewha Medical Research Institute, Ewha Womans University, Seoul, Korea.

Gain Lee (G)

Department of Obstetrics and Gynecology, College of Medicine, Ewha Medical Research Institute, Ewha Womans University, Seoul, Korea.
System Health & Engineering Major in Graduate School (BK21 Plus Program, Seoul, Korea.

Soo Min Kim (SM)

Department of Obstetrics and Gynecology, College of Medicine, Ewha Medical Research Institute, Ewha Womans University, Seoul, Korea.
System Health & Engineering Major in Graduate School (BK21 Plus Program, Seoul, Korea.

AbuZar Ansari (A)

Department of Obstetrics and Gynecology, College of Medicine, Ewha Medical Research Institute, Ewha Womans University, Seoul, Korea.

Young-Ah You (YA)

Department of Obstetrics and Gynecology, College of Medicine, Ewha Medical Research Institute, Ewha Womans University, Seoul, Korea.

Yun Ji Jung (YJ)

Department of Obstetrics and Gynecology, College of Medicine, Yonsei University, Seoul, Korea.

Young-Han Kim (YH)

Department of Obstetrics and Gynecology, College of Medicine, Yonsei University, Seoul, Korea.

Myunghoon Lee (M)

D&P Biotech, Inc, Seoul, Korea.

Young Ju Kim (YJ)

Department of Obstetrics and Gynecology, College of Medicine, Ewha Medical Research Institute, Ewha Womans University, Seoul, Korea.
System Health & Engineering Major in Graduate School (BK21 Plus Program, Seoul, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH